Interim results of a phase II single arm trial combining afatinib with cetuximab in patients with EGFRex20ins positive NSCLC.

Bianca van Veggel; Anthonie J. van der Wekken; Marthe Paats; Sayed MS Hashemi; Lizza Hendriks; Karolina Sikorska; Daan van den Broek; Kim Monkhorst; Egbert F. Smit; Joop De Langen

doi:https://doi.org/10.1200/JCO.2021.39.15_suppl.9112

Interim results of a phase II single arm trial combining afatinib with cetuximab in patients with EGFRex20ins positive NSCLC.

Bianca van Veggel, Anthonie J. van der Wekken, Marthe Paats, Sayed MS Hashemi, Lizza Hendriks, Karolina Sikorska, Daan van den Broek, Kim Monkhorst, Egbert F. Smit, Joop De Langen

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

9112

Original language	English
Journal	Journal of clinical oncology
Volume	39
Issue number	15_suppl
DOIs	https://doi.org/10.1200/JCO.2021.39.15_suppl.9112
Publication status	Published - 2021

Access to Document

https://doi.org/10.1200/JCO.2021.39.15_suppl.9112

Cite this

van Veggel, B., van der Wekken, A. J., Paats, M., Hashemi, S. MS., Hendriks, L., Sikorska, K., van den Broek, D., Monkhorst, K., Smit, E. F., & De Langen, J. (2021). Interim results of a phase II single arm trial combining afatinib with cetuximab in patients with EGFRex20ins positive NSCLC. Journal of clinical oncology, 39(15_suppl). https://doi.org/10.1200/JCO.2021.39.15_suppl.9112

@article{af1c15849f224f8296688349b7d2b38b,

title = "Interim results of a phase II single arm trial combining afatinib with cetuximab in patients with EGFRex20ins positive NSCLC.",

abstract = "9112",

author = "{van Veggel}, Bianca and {van der Wekken}, {Anthonie J.} and Marthe Paats and Hashemi, {Sayed MS} and Lizza Hendriks and Karolina Sikorska and {van den Broek}, Daan and Kim Monkhorst and Smit, {Egbert F.} and {De Langen}, Joop",

year = "2021",

doi = "https://doi.org/10.1200/JCO.2021.39.15_suppl.9112",

language = "English",

volume = "39",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15_suppl",

}

van Veggel, B, van der Wekken, AJ, Paats, M, Hashemi, SMS, Hendriks, L, Sikorska, K, van den Broek, D, Monkhorst, K, Smit, EF & De Langen, J 2021, 'Interim results of a phase II single arm trial combining afatinib with cetuximab in patients with EGFRex20ins positive NSCLC.', Journal of clinical oncology, vol. 39, no. 15_suppl. https://doi.org/10.1200/JCO.2021.39.15_suppl.9112

TY - JOUR

T1 - Interim results of a phase II single arm trial combining afatinib with cetuximab in patients with EGFRex20ins positive NSCLC.

AU - van Veggel, Bianca

AU - van der Wekken, Anthonie J.

AU - Paats, Marthe

AU - Hashemi, Sayed MS

AU - Hendriks, Lizza

AU - Sikorska, Karolina

AU - van den Broek, Daan

AU - Monkhorst, Kim

AU - Smit, Egbert F.

AU - De Langen, Joop

PY - 2021

Y1 - 2021

N2 - 9112

AB - 9112

U2 - https://doi.org/10.1200/JCO.2021.39.15_suppl.9112

DO - https://doi.org/10.1200/JCO.2021.39.15_suppl.9112

M3 - Article

SN - 0732-183X

VL - 39

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15_suppl

ER -